Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.30 |
| ▸ | SMPD1 | P17405 | 3/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11467129 | 1.00 | TSHR (0.39) | TSHRALDH1A1TDP1SMPD1 | |
| SCHEMBL8053054 | 0.97 | TSHR (0.35) | TSHRALDH1A1TDP1 | |
| SCHEMBL1769976 | 0.89 | — | — | |
| SCHEMBL31543742 | 0.86 | TSHR (0.32) | TSHRALDH1A1TDP1 | |
| SCHEMBL5160133 | 0.86 | SMPD1 (0.36) | SMPD1 | |
| SCHEMBL7934687 | 0.86 | SMPD1 (0.36) | SMPD1 | |
| SCHEMBL7936797 | 0.86 | SMPD1 (0.36) | SMPD1 | |
| SCHEMBL7934735 | 0.86 | SMPD1 (0.36) | SMPD1 | |
| SCHEMBL6567377 | 0.86 | SMPD1 (0.36) | SMPD1 | |
| SCHEMBL6298010 | 0.83 | SMPD1 (0.32) | SMPD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 123 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4025246-A2 | IMMUNOGENIC COMPOSITIONS AGAINST ENTERIC DISEASES AND METHODS FOR ITS PREPARATION THEREOF | Serum Institute Of India Private Limited (IN) | 2022-07-13 | — | — | EP | claimed |
| CN-114728053-A | Immunogenic compositions against intestinal disease and process for preparing same | 印度血清研究所私人有限公司 | 2022-07-08 | — | — | CN | claimed |
| WO-2021044436-A2 | IMMUNOGENIC COMPOSITIONS AGAINST ENTERIC DISEASES AND METHODS FOR ITS PREPARATION THEREOF | SERUM INSTITUTE OF INDIA PRIVATE LIMITED (IN) | 2021-03-11 | — | — | WO | claimed |
| EP-2387417-B1 | BROAD SPECTRUM VACCINE AGAINST NON-TYPHOIDAL SALMONELLA | UNIV MARYLAND (US) | 2016-05-11 | — | — | EP | claimed |
| US-9050283-B2 | Broad spectrum vaccine against non-typhoidal Salmonella | UNIVERSITY OF MARYLAND, BALTIMORE (US) | 2015-06-09 | — | — | US | claimed |
| CN-102964287-B | Synthesis method of 3-(4-chlorobutyl)-5-cyanoindole | SUZHOU UUGENE BIOPHARMA CO LTD | 2014-04-09 | — | — | CN | claimed |
| CN-102964287-A | New synthesis method of 3-(4-chlorobutyl)-5-cyanoindole | SUZHOU UUGENE BIOPHARMA CO LTD | 2013-03-13 | — | — | CN | claimed |
| WO-2012061400-A2 | METHOD FOR REDUCTION OF FREE POLYSACCHARIDE IN POLYSACCHARIDE-PROTEIN VACCINES REACTIONS USING ION-EXCHANGE MATRICES | UNIVERSITY OF MARYLAND, BALTIMORE (US) | 2012-05-10 | — | — | WO | claimed |
| EP-2387417-A2 | BROAD SPECTRUM VACCINE AGAINST NON-TYPHOIDAL SALMONELLA | University of Maryland, Baltimore (US) | 2011-11-23 | — | — | EP | claimed |
| US-20110274714-A1 | Broad Spectrum Vaccine Against Non-Typhoidal Salmonella | UNIVERSITY OF MARYLAND, BALTIMORE (US) | 2011-11-10 | — | — | US | claimed |
| US-20040115214-A1 | Lipooligosaccharide-based vaccine for prevention of Moraxella (Branhamella) catarrhalis infections in humans | GU XIN-XING (US) | 2004-06-17 | — | — | US | claimed |
| US-6685949-B1 | OTITIS MEDIA AND SINUSITIS; DETOXIFIED BY TREATING TO REMOVE ESTERIFIED FATTY ACIDS, IMMUNOGENIC CARRIER PROTEIN COVALENTLY LINKED THERETO | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH & HUMAN SERVICES | 2004-02-03 | — | — | US | claimed |
| WO-2003070282-A2 | SYNTHESIS OF LIPOPOLYSACCHARIDE-PROTEIN CONJUGATE VACCINES VIA THE LIPID A REGION FOLLOWING REMOVAL OF THE GLYCOSIDIC PHOSPHATE RESIDUE | NATIONAL RESEARCH COUNCIL OF CANADA (CA) | 2003-08-28 | — | — | WO | claimed |
| US-6607725-B2 | Complex of lipooligosaccharide and immunology carriers | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES | 2003-08-19 | — | — | US | claimed |
| US-6531131-B1 | Neisseria meningitidis lipooligosaccharide from which at least one primary O-linked fatty acid has been removed to detoxify it, covalently linked to immunogenic carrier | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES | 2003-03-11 | — | — | US | claimed |
| US-20020001589-A1 | Conjugate vaccine for nontypeable haemophilus influenzae | GU XIN-XING (US) | 2002-01-03 | — | — | US | claimed |
| US-6207157-B1 | OLIGOSACCHARIDE | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES | 2001-03-27 | — | — | US | claimed |
| EP-1047447-A1 | LIPOOLIGOSACCHARIDE-BASED VACCINE FOR PREVENTION OF $i(MORAXELLA) $i((BRANHAMELLA)) $i(CATARRHALIS) INFECTIONS IN MAMMALS | THE UNITED STATES GOVERNMENT as represented by THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2000-11-02 | — | — | EP | claimed |
| WO-1999036086-A1 | LIPOOLIGOSACCHARIDE-BASED VACCINE FOR PREVENTION OF MORAXELLA (BRANHAMELLA) CATARRHALIS INFECTIONS IN MAMMALS | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1999-07-22 | — | — | WO | claimed |
| WO-1998026799-A1 | CONJUGATE VACCINE FOR SALMONELLA PARATYPHI A | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1998-06-25 | — | — | WO | claimed |